When was Pepex founded?

Pepex was founded in 2001 and raised its 1st funding round 11 years after it was founded.

Where is Pepex located?

Pepex is headquartered in Saint Louis, United States.

How many employees does Pepex have?

As of May 31, 2026, the latest employee count at Pepex is 6.

Is Pepex a funded company?

Pepex is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Apr 26, 2012.

When was the latest funding round of Pepex?

Pepex's latest funding was a $***** Seed round on Apr 26, 2012, with participation from 0 investor. Its primary sector is Diabetes. In United States, the Diabetes sector has seen $201M in funding in 2026 to date.

Where does Pepex rank among its competitors?

Pepex ranks 36th amongst 96 active competitors, of which 10 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Intuity Medical, which secured $26.3M in May, 2019.

Who are the top competitors of Pepex?

Pepex's top competitors include Beurer UK, i-SENS and Ascensia. Among them, Intuity Medical secured the most recent funding round in May, 2019.

Pepex - 2026 Company Profile, Funding & Competitors

Company Details

Pepex is a medical device company focusing on the development, manufacturing, and marketing of disposable, miniaturized electrochemical biosensors. The company protects its market opportunities with 64 patents which encompass a broad spectrum of proprietary including sensor chemistry and architecture, to wireless communications for the sensors, to laser welding manufacturing processes. Its product, Trio, a fully-integrated, all-in-one blood glucose meter for painless testing with no lancet or blood droplet required. It offers up to 20 fully complete glucose tests in a small disposable cartridge.

Key Metrics

Founded Year

2001

Location

Saint Louis, United States

Stage

Seed

Total Funding

$202K in 1 round

Latest Funding Round

Seed, Apr 26, 2012, $*****

Ranked

36^th among 96 active competitors

Employee Count

6 as on May 31, 2026

Similar Companies

Beurer UK & 142 more

View Pepex's full profile

Pepex is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Pepex Biomedical, Inc CIN: 330686549 , United States, Active	Jul 16, 2019	-	-	-

Pepex has raised a total funding of $202K over 1 round.

Here is the list of recent funding rounds of Pepex:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 26, 2012	6185327	Seed	9547313	3762396	4246119	6896729

Access funding benchmarks and valuations. Sign up today!

View details of Pepex's funding rounds and investors

Pepex's employee count trend

Pepex has 6 employees as of May 26. Here is Pepex's employee count trend over the years:

Uncover Pepex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pepex include Beurer UK, i-SENS and Ascensia. Here is the list of Top 10 competitors of Pepex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Beurer UK 1999, Ulm (Germany), Unfunded	Developer of medical products and consumer devices	-	-	61/100
2nd	i-SENS 2000, Zhangjiagang (China), Public	Developer of blood glucose monitoring and clinical chemistry analyzers	-	IMM Investment, STIC Ventures & 8 others	60/100
3rd	Ascensia 2013, Basel (Switzerland), Unfunded	Developer of glucose monitoring systems and diabetes management software	-	-	59/100
4th	Telcare 2008, Bethesda (United States), Acquired	Cellular technology and social networking to tackle diabetes	$66.7M	Sequoia Capital, Echo Health Ventures & 4 others	54/100
5th	Trividia Health 1985, Fort Lauderdale (United States), Acquired	Innovative diabetes solutions provider dedicated to healthier lives through affordable products	-	-	53/100
6th	Intuity Medical 2002, San Francisco (United States), Series F	All-in-one blood glucose monitoring system	$258M	Venrock, Investor Growth Capital & 15 others	52/100
7th	Biosense 2008, Mumbai (India), Acquired	Developer of diagnostic devices for multiple diseases	$3.94M	Insitor Partners, Menterra Venture Advisors ... & 29 others	52/100
8th	LifeScan 1996, Chesterbrook (United States), Acquired	Innovating diabetes management solutions, empowering healthier lives through technology and partnerships	-	ABS Ventures, Sutter Hill Ventures	50/100
9th	Smart Meter 2009, Tampa (United States), Unfunded	Cloud-based remote patient monitoring solutions for healthcare providers	-	-	49/100
10th	Sinocare 2002, Changsha (China), Funding Raised	Develops and markets POC devices	-	Broad Vision Funds, Lotus Lake Capital Management	45/100
36th	Pepex 2001, Saint Louis (United States), Seed	All-in-one blood glucose meter	$202K	-	28/100